share_log

HLS Therapeutics Inc: 52109F2 CERTIFICATION OF INTERIM FILINGS CFO EN

SEDAR ·  Nov 7 07:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more